Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

534 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transfected human dendritic cells to induce antitumor immunity.
Rughetti A, Biffoni M, Sabbatucci M, Rahimi H, Pellicciotta I, Fattorossi A, Pierelli L, Scambia G, Lavitrano M, Frati L, Nuti M. Rughetti A, et al. Among authors: frati l. Gene Ther. 2000 Sep;7(17):1458-66. doi: 10.1038/sj.gt.3301266. Gene Ther. 2000. PMID: 11001365
Regulated expression of MUC1 epithelial antigen in erythropoiesis.
Rughetti A, Biffoni M, Pierelli L, Rahimi H, Bonanno G, Barachini S, Pellicciotta I, Napoletano C, Pescarmona E, Del Nero A, Pignoloni P, Frati L, Nuti M. Rughetti A, et al. Among authors: frati l. Br J Haematol. 2003 Jan;120(2):344-52. doi: 10.1046/j.1365-2141.2003.04038.x. Br J Haematol. 2003. PMID: 12542497 Free article.
Immunogenicity of allo-vesicle carrying ERBB2 tumor antigen for dendritic cell-based anti-tumor immunotherapy.
Napoletano C, Rughetti A, Landi R, Pinto D, Bellati F, Rahimi H, Spinelli GP, Pauselli S, Sale P, Dolo V, De Lorenzo F, Tomao F, Benedetti-Panici P, Frati L, Nuti M. Napoletano C, et al. Among authors: frati l. Int J Immunopathol Pharmacol. 2009 Jul-Sep;22(3):647-58. doi: 10.1177/039463200902200310. Int J Immunopathol Pharmacol. 2009. PMID: 19822081 Free article.
HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy.
Zizzari IG, Veglia F, Taurino F, Rahimi H, Quaglino E, Belleudi F, Riccardo F, Antonilli M, Napoletano C, Bellati F, Benedetti-Panici P, Torrisi MR, Frati L, Nuti M, Rughetti A. Zizzari IG, et al. Among authors: frati l. J Mol Med (Berl). 2011 Dec;89(12):1231-40. doi: 10.1007/s00109-011-0794-7. Epub 2011 Aug 16. J Mol Med (Berl). 2011. PMID: 21845448 Free PMC article.
534 results